Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 651 across all filing types
Latest filing 2019-03-07 Regulatory Filings
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by GemVax & Kael. It details the patent name, content, patent holder, and utilization plan. Since this is a regulatory announcement regarding a specific corporate event that does not fall into the categories of financial reports, shareholder meetings, or management changes, it is classified as a general regulatory filing.
2019-03-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership by major shareholders and their special related parties, including transaction dates, methods, and purposes. It does not fit into categories like 10-K, Earnings Release, or Investor Presentation. Since it is a specific regulatory disclosure regarding shareholding thresholds, it falls under the 'Major Shareholding Notification' category.
2019-03-06 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company GemVax. It details the patent name, content, patent holder, and utilization plan. Since this is a specific regulatory announcement regarding a corporate event that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2019-03-04 Korean
전환가액의조정(제11회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company. This type of disclosure, which details changes to the capital structure and conversion terms of debt instruments, falls under the category of capital and financing updates.
2019-02-28 Korean
전환가액의조정(제12회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company. It details the change in conversion price, the number of convertible shares, and the underlying reason (market price decline). This type of disclosure regarding capital structure changes, specifically related to convertible securities, falls under the 'Capital/Financing Update' category.
2019-02-28 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (GemVax) regarding the acquisition of a patent. It follows the standard format for 'Other Management Matters' (기타 경영사항) filings on the KRX (Korea Exchange). Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a formal regulatory announcement, it falls under the general regulatory filing category.
2019-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.